Clinical
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Action Update, February 2026: Complete Response Letter, Expanded Indication, and Acceptance
2
WVE-N531 Shows Sustained Dystrophin Production in Phase 2 Trial of Duchenne Muscular Dystrophy
3
Real-World Study Suggests Motor Gains in SMA After Switching to Onasemnogene Abeparvovec From Nusinersen or Risdiplam Treatment
4
Long-Term Data From PARADIGM Trial Suggest Survival Benefit With PrimeC in ALS
5